Featured Research

from universities, journals, and other organizations

Jefferson Neurosurgeons Use New Procedure To Reverse Dangerous Cerebral Vasospasm

Date:
October 14, 1998
Source:
Thomas Jefferson University
Summary:
Neurosurgeons at Jefferson Medical College have developed a method to reverse dangerous cerebral vasospasms. Vasospasm is a narrowing of cerebral arteries several days after aneurysm rupture. It is the leading cause of neurological disability and death in survivors of ruptured aneurysms.

Neurosurgeons at Jefferson Medical College have developed a method to reverse dangerous cerebral vasospasms. Vasospasm is a narrowing of cerebral arteries several days after aneurysm rupture. It is the leading cause of neurological disability and death in survivors of ruptured aneurysms.

Related Articles


Jeffrey Thomas, M.D., assistant professor of neurosurgery at Thomas Jefferson University in Philadelphia, and his colleagues have so far successfully treated 16 patients since March 1997. Each patient had failed conventional treatment for vasospasm.

"Clinical outcomes in treatment of these patients have been excellent, even in some patients with coma and partial paralysis before treatment," says Dr. Thomas. "Most of these patients have survived without significant neurological deficit from vasospasm." The neurosurgeons used a class of drug that dilates the cerebral blood vessels. According to Dr. Thomas, the drug is given by a specialized neurosurgical technique.

The drug is given immediately in the space around the brain and into the cerebrospinal fluid, which bathes the brain. The drug expands the brain's blood vessels, reversing the constricting effects of the vasospasm within about 30 minutes. The treatment currently is being evaluated as a preventive measure for ischemic stroke from vasospasm, with very encouraging initial results. Dr. Thomas presented his results last week at the Congress of Neurological Surgeons in Seattle.

A ruptured aneurysm is a hemorrhagic stroke, one of two types of stroke (the other is ischemic, caused by a reduced blood flow to the brain). When an aneurysm, which is a weakness in a blood vessel wall, erupts in the brain, it spills blood into the subarachnoid space around the brain. This is called a subarachnoid hemorrhage.

Neurosurgeons can operate and eliminate the aneurysm by placing a titanium clip or by a new less invasive procedure called coil embolization. In this procedure, the cerebral aneurysm is eliminated through a tiny incision in the patient's leg. These surgeries are generally successful. A week later, however, cerebral vasospasm can occur. Blood vessels constrict, which may be severe enough to cause ischemic stroke.

"Although patients survive the hemorrhage and come through surgery well, and the aneurysm is cured, the patient may suffer an ischemic stroke from vasospasm up to two weeks later, despite appearing well initially," Dr. Thomas explains. "The exact reasons are unclear, though recent advances in molecular biology have shed light on the mechanism." He has been studying this on the molecular level for about five years.

About 30,000 people a year in North America are candidates for such a procedure to treat cerebral vasospasm, he says, and about 10-12 of every 100,000 worldwide. Roughly 30 percent of patients develop the potentially life-threatening or disabling type of vasospasm.

"No one has ever had a specific and reliable treatment for cerebral vasospasm. It has potential to save lives and get people out of the hospital sooner, and save health care dollars as well," Dr. Thomas says.

"People with ruptured aneurysms are among the sickest patients in medicine, with hospital stays of months. A hospital stay for a patient complicated by vasospasm may cost a half million dollars. And half of those who survive the aneurysm need rehabilitation. If we can eliminate vasospasm as a complication, we can save resources as well as lives."


Story Source:

The above story is based on materials provided by Thomas Jefferson University. Note: Materials may be edited for content and length.


Cite This Page:

Thomas Jefferson University. "Jefferson Neurosurgeons Use New Procedure To Reverse Dangerous Cerebral Vasospasm." ScienceDaily. ScienceDaily, 14 October 1998. <www.sciencedaily.com/releases/1998/10/981014073824.htm>.
Thomas Jefferson University. (1998, October 14). Jefferson Neurosurgeons Use New Procedure To Reverse Dangerous Cerebral Vasospasm. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/1998/10/981014073824.htm
Thomas Jefferson University. "Jefferson Neurosurgeons Use New Procedure To Reverse Dangerous Cerebral Vasospasm." ScienceDaily. www.sciencedaily.com/releases/1998/10/981014073824.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) — Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) — AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) — Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins